Banco Bilbao Vizcaya Argentaria S.A. Has $3.67 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 169,937 shares of the company's stock after selling 17,800 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Kenvue were worth $3,666,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in KVUE. Bard Financial Services Inc. lifted its holdings in Kenvue by 5.7% during the 3rd quarter. Bard Financial Services Inc. now owns 106,790 shares of the company's stock valued at $2,470,000 after purchasing an additional 5,750 shares during the last quarter. Boyar Asset Management Inc. raised its stake in shares of Kenvue by 7.2% in the third quarter. Boyar Asset Management Inc. now owns 29,171 shares of the company's stock valued at $675,000 after acquiring an additional 1,948 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Kenvue in the 3rd quarter worth approximately $1,057,000. Tidal Investments LLC increased its holdings in Kenvue by 9.9% during the 3rd quarter. Tidal Investments LLC now owns 131,128 shares of the company's stock valued at $3,033,000 after purchasing an additional 11,849 shares in the last quarter. Finally, Oddo BHF Asset Management Sas bought a new stake in shares of Kenvue during the third quarter worth $1,570,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on KVUE shares. Redburn Atlantic initiated coverage on Kenvue in a research note on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target on the stock. Canaccord Genuity Group increased their price objective on shares of Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a report on Wednesday, March 5th. Citigroup increased their target price on Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a research note on Monday, April 14th. Royal Bank of Canada reissued a "sector perform" rating and issued a $24.00 price target on shares of Kenvue in a report on Monday, February 3rd. Finally, UBS Group lowered their target price on Kenvue from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, Kenvue currently has a consensus rating of "Hold" and a consensus price target of $24.42.

Kenvue Price Performance

Kenvue stock traded up $0.12 during trading hours on Wednesday, reaching $23.50. 4,604,635 shares of the stock were exchanged, compared to its average volume of 17,053,325. The stock has a 50 day moving average of $23.06 and a two-hundred day moving average of $22.46. The company has a market cap of $45.09 billion, a P/E ratio of 44.34, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.49%. The ex-dividend date of this dividend is Wednesday, May 14th. Kenvue's dividend payout ratio (DPR) is presently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.